Patents by Inventor Unja Martin

Unja Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel murine and human kinases
    Publication number: 20080076141
    Abstract: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Application
    Filed: September 14, 2007
    Publication date: March 27, 2008
    Applicant: Immunex Corporation
    Inventors: Timothy Bird, G. Virca, Unja Martin, Dirk Anderson
  • Antibodies to novel murine and human kinases
    Patent number: 7285643
    Abstract: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: October 23, 2007
    Assignee: Immunex Corporation
    Inventors: Timothy A. Bird, G. Duke Virca, Unja Martin, Dirk M. Anderson
  • Murine and human kinases
    Patent number: 7001752
    Abstract: The inventions is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acid encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: February 21, 2006
    Assignee: Immunex Corporation
    Inventors: Timothy A. Bird, G. Duke Virca, Unja Martin, Dirk M. Anderson
  • Antibodies to novel murine and human kinases
    Publication number: 20060024807
    Abstract: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Application
    Filed: September 30, 2005
    Publication date: February 2, 2006
    Applicant: Immunex Corporation
    Inventors: Timothy Bird, G. Virca, Unja Martin, Dirk Anderson
  • Calcium/calmodulin-dependent kinase
    Patent number: 6759223
    Abstract: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: July 6, 2004
    Assignee: Immunex Corporation
    Inventors: Timothy A. Bird, G. Duke Virca, Unja Martin, Dirk M. Anderson
  • Calcium/calmodulin-dependent kinase
    Publication number: 20030162277
    Abstract: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Application
    Filed: January 30, 2003
    Publication date: August 28, 2003
    Applicant: Immunex Corporation
    Inventors: Timothy A. Bird, G. Duke Virca, Unja Martin, Dirk M. Anderson
  • Methods for identifying compounds that alter kinase activity
    Patent number: 6514719
    Abstract: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: February 4, 2003
    Assignee: Immunex Corporation
    Inventors: Timothy A. Bird, G. Duke Virca, Unja Martin, Dirk M. Anderson